Literature DB >> 16750877

Investigating the sustainability of outcomes in a chronic disease treatment programme.

Ross S Bailie1, Gary Robinson, Srinivas N Kondalsamy-Chennakesavan, Stephen Halpin, Zhiqiang Wang.   

Abstract

This study examines trends in chronic disease outcomes from initiation of a specialised chronic disease treatment programme through to incorporation of programme activities into routine service delivery. We reviewed clinical records of 98 participants with confirmed renal disease or hypertension in a remote indigenous community health centre in Northern Australia. For each participant the review period spanned an initial three years while participating in a specialised cardiovascular and renal disease treatment programme and a subsequent three years following withdrawal of the treatment programme. Responsibility for care was incorporated into the comprehensive primary care service which had been recently redeveloped to implement best practice care plans. The time series analysis included at least six measures prior to handover of the specialised programme and six following handover. Main outcome measures were trends in blood pressure (BP) control, and systolic and diastolic BP. We found an improvement in BP control in the first 6-12 months of the programme, followed by a steady declining trend. There was no significant difference in this trend between the pre- compared to the post-programme withdrawal period. This finding was consistent for control at levels below 130/80 and 140/90, and for trends in mean systolic and diastolic BP. Investigation of the sustainability of programme outcomes presents major challenges for research design. Sustained success in the management of chronic disease through primary care services requires better understanding of the causal mechanisms related to clinical intervention, the basis upon which they can be 'institutionalised' in a given context, and the extent to which they require regular revitalisation to maintain their effect.

Entities:  

Mesh:

Year:  2006        PMID: 16750877     DOI: 10.1016/j.socscimed.2006.04.010

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  The authors respond.

Authors:  Sarah Bowen; Sara A Kreindler
Journal:  Healthc Policy       Date:  2008-05

2.  Early identification and preventive care for elevated cardiovascular disease risk within a remote Australian Aboriginal primary health care service.

Authors:  Christopher P Burgess; Ross S Bailie; Christine M Connors; Richard D Chenhall; Robyn A McDermott; Kerin O'Dea; Charlie Gunabarra; Hellen L Matthews; Adrian J Esterman
Journal:  BMC Health Serv Res       Date:  2011-01-31       Impact factor: 2.655

Review 3.  The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research.

Authors:  Shannon Wiltsey Stirman; John Kimberly; Natasha Cook; Amber Calloway; Frank Castro; Martin Charns
Journal:  Implement Sci       Date:  2012-03-14       Impact factor: 7.327

4.  Geographical analysis of evaluated chronic disease programs for Aboriginal and Torres Strait Islander people in the Australian primary health care setting: a systematic scoping review.

Authors:  Hannah Beks; Marley J Binder; Constance Kourbelis; Geraldine Ewing; James Charles; Yin Paradies; Robyn A Clark; Vincent L Versace
Journal:  BMC Public Health       Date:  2019-08-14       Impact factor: 3.295

5.  Reported sources of health inequities in Indigenous Peoples with chronic kidney disease: a systematic review of quantitative studies.

Authors:  Tania Huria; Suzanne G Pitama; Lutz Beckert; Jaquelyne Hughes; Nathan Monk; Cameron Lacey; Suetonia C Palmer
Journal:  BMC Public Health       Date:  2021-07-23       Impact factor: 3.295

6.  Integrating new practices: a qualitative study of how hospital innovations become routine.

Authors:  Amanda L Brewster; Leslie A Curry; Emily J Cherlin; Kristina Talbert-Slagle; Leora I Horwitz; Elizabeth H Bradley
Journal:  Implement Sci       Date:  2015-12-05       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.